At the end of this uniquely challenging year, MVG Consulting would like to take a moment to thank those who have had an indelible impact throughout this difficult time. To the frontline workers, who have worked tirelessly, adapting to every changing circumstance this pandemic has forced upon us. To those working remotely, who have had to […]
Heading towards the inevitable? COVID-19 paves the way for decentralized trials The pandemic has become a showcase for decentralized research that uses telemedicine and mobile tools to accelerate the pace of discovery. Source: How Covid-19 could drive a shift toward decentralized clinical trials
Technological innovation within the Pharmaceutical industry is on a clear path towards continued growth, and with that comes the opportunity for new players to get involved. Outside of speed and efficiency, the integration of technology also allows increased accessibility for companies perhaps not otherwise suited to infiltrate the industry. Virtual Pharma companies are a great […]
The speed with which COVID-19 vaccines are being developed leaves many uncertain about the safety and effectiveness of a potential vaccine. The global conference hosted by Harvard and MIT confronts this uncertainty and probes the question of how to evaluate and regulate drug development moving forward. Technology will play a central role in upcoming innovation, […]
When it comes to hiring the right talent to help a company succeed, the tradition has typically been to hire full-time talent that can be groomed to the culture and processes of a specific firm. However, investing in full time employees is costly, and doesn’t always ensure the productivity necessary to make that investment worthwhile. Thankfully, […]
Looking for new consulting work? Check out our open contractor positions at MVG: Manager of Clinical Quality Systems Clinical Quality Assurance Auditor Clinical Trial Manager Clinical Project Manager Medical Writer Contact MVG today with inquiries!
COVID-19 has left a trail of uncertainty in its wake as the burden weighing on pharmaceutical companies working to get their clinical trials back on track appears somewhat insurmountable. These challenges facing the pharmaceutical industry are multifaceted as the number of trials previously put on hold now looking to reconvene is compounded by the growing […]
While the speedy development of a COVID-19 vaccine lends itself to a faster “return to normal”, the expedience raises some very legitimate concerns about the quality of such a rushed product. Due to the immense pressure to approve a vaccine quickly, a subpar and potentially dangerous vaccine may be on the fast track to approval […]
The Time is Now. The pharmaceutical industry is laden with issues and inefficiencies that, as of late, have been illuminated and exacerbated. Much of the issue lies in the industry’s sluggish digital transformation as so many of the shortfalls that the system currently grapples with, would be largely improved with the assistance of technology. There […]
Great read on the latest COVID-related regulatory developments, namely the FDA’s announcement on treatment efficacy thresholds for upcoming vaccines. A week after the US Food and Drug Administration (FDA) issued guidance on vaccines to prevent coronavirus disease (COVID-19), Peter Marks, director of the Center for Biologics Evaluation and Research, shed light on the reasoning […]